Back to RTW INVESTMENTS, LP RTW INVESTMENTS, LP

RARERARE
Showing 8 of 19 quarters

Position history for RTW INVESTMENTS, LPRTW INVESTMENTS, LP's holdings in Ultragenyx Pharmaceutical, Inc.

RTW INVESTMENTS, LP holds 7.8M shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $260.3M as of 2026-Q2. The position was increased (+113.7% shares). RARE represents 2.2% of RTW INVESTMENTS, LP's portfolio.

Current Value

$260.3M

Current Shares

7.8M

Total Value Change

+$151M

Total Shares Change

+5.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.8M
+113.7%
$260.3M2.2%$33.39
85
2026-Q1
Increased
3.6M
+21.6%
$76.4M0.8%$22.07
50
2025-Q4
Decreased
3M
-7.9%
$69M0.7%$22.78
0
2025-Q3
Increased
3.3M
+90.8%
$98M1.2%$30.36
74
2025-Q2
Unchanged
1.7M
0.0%
$62.1M0.9%$36.52
0
2025-Q1
Decreased
1.7M
-13.2%
$61.8M0.9%$37.82
0
2024-Q4
Unchanged
2M
0.0%
$82.8M1.3%$42.27
0
2024-Q3
Decreased
2M
-39.6%
$109.3M1.6%$54.43
0

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used